Product Specifications Research Overview Cagrilintide is a long-acting acylated analogue of human amylin, developed by Novo Nordisk under the codes AM833 and NNC0174-0833, with the molecular formula CHNOS, a molecular weight of 4409.0 g/mol and CAS number 1415456-99-3
For the open-label treatment extension period analysis, only the efficacy estimand was used due to the lack of a true placebo group
Figure: White exudate and cobblestone appearance of mucosa of the left colon consistent with ischemic colitis Figure: Colonic mucosa showing ulceration, withering crypts, crypt dropout, and lamina propria and submucosal hyalinization consistent with ischemic colitis (10X) Disclosures: Nancy Mayer indicated no relevant financial relationships
I didnt get a chance to dive in deep, but there where some noteworthy headlines to take into consideration
Yes, many patients transition between injection and oral formulations based on lifestyle changes or personal preference